Business
Premium

Cannabis start-up investors in the dark on failed $180m deal

A $180 million deal with Rhizo Sciences is up in smoke but PlegeMe investors haven't been told.
 

Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login